This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Kaohsiung Medical University. Active years: 2014-2023.
Company Filing History:
Years Active: 2014-2023
Title: Yen-Hsu Chen: Innovator in Medical Treatments
Introduction
Yen-Hsu Chen is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of medical treatments, particularly in addressing various infections and diseases. With a total of 3 patents, his work has the potential to impact healthcare positively.
Latest Patents
Yen-Hsu Chen's latest patents include innovative methods for treating subjects suffering from flavivirus infections. One of his notable inventions discloses a method that involves administering a pharmaceutical composition containing a pharmaceutically effective amount of an anti-CD44 antibody. This method aims to provide effective treatment for those affected by flavivirus infections.
Another significant patent focuses on combating bacterial infections, inflammation, and leukemia. This method involves administering an effective amount of Tellimagrandin II, along with its pharmaceutically acceptable salt, enantiomer, isomer, or tautomer, to inhibit the growth of Gram-positive bacteria, including methicillin-resistant strains. Additionally, this patent outlines methods for treating sepsis and leukemia using Tellimagrandin II.
Career Highlights
Yen-Hsu Chen is affiliated with Kaohsiung Medical University, where he continues to advance his research and innovations. His work is characterized by a commitment to developing effective treatments for serious health conditions.
Collaborations
Yen-Hsu Chen collaborates with esteemed colleagues, including Lih-Geeng Chen and Chin Hsu, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the medical field.
Conclusion
Yen-Hsu Chen's innovative contributions to medical treatments demonstrate his dedication to improving healthcare outcomes. His patents reflect a commitment to addressing critical health challenges through scientific advancements.